ayahuasca
Botanicalexperimental
Ayahuasca is a South American psychoactive decoction prepared from Banisteriopsis caapi vine and a dimethyltryptamine (DMT)-containing plant, used by Indigenous cultures in the Amazon and Orinoco basins as part of traditional medicine and shamanism. The word ayahuasca, originating from Quechuan languages spoken in the Andes, refers both to the B. caapi vine and the psychoactive brew made from it, with its name meaning "spirit rope" or "liana of the soul." — Wikipedia
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT02914769)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAyahuasca ↗
Also known as
- ayahuasca
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05894902 | Phase 1 | Oct 1, 2023 | — |
| NCT07212946 | Phase 2 | Oct 30, 2022 | University of Sao Paulo |
| NCT06150859 | Phase 2 | Oct 15, 2021 | Badalona Hospital Germans Trias i Pujol, Beckley Foundation |
| NCT02914769 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Brain Institute - UFRN, Universidade Federal do Rio Grande do Norte, University of Sao Paulo |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Sao Paulo | Academic/Hospital | 2 | 1 | 1 | 2014 |
| Badalona Hospital Germans Trias i Pujol | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Beckley Foundation | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Brain Institute - UFRN | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Universidade Federal do Rio Grande do Norte | Academic/Hospital | 1 | 1 | 1 | 2014 |
5 organizations
Page 1 / 1